,Collection,PatientID,PatientName,PatientSex,StudyInstanceUID,StudyDate,StudyDescription,SeriesCount
0,PDMR-BL0293-F563,BL0293-F563-40,BL0293-F563-40,F,1.3.46.670589.11.17169.5.0.5032.2015073113554247668,2015-07-31,NCI PDMR Tumor Characterization,2
1,PDMR-BL0293-F563,BL0293-F563-40,BL0293-F563-40,F,1.3.46.670589.11.17169.5.0.5244.2015071308371773341,2015-07-13,NCI PDMR Tumor Characterization,2
2,PDMR-BL0293-F563,BL0293-F563-42,BL0293-F563-42,F,1.3.46.670589.11.17169.5.0.5032.2015073012110374491,2015-07-30,NCI PDMR Tumor Characterization,2
3,PDMR-BL0293-F563,BL0293-F563-42,BL0293-F563-42,F,1.3.46.670589.11.17169.5.0.5244.2015071309172670351,2015-07-13,NCI PDMR Tumor Characterization,2
4,PDMR-BL0293-F563,BL0293-F563-44,BL0293-F563-44,F,1.3.46.670589.11.17169.5.0.5032.2015073009393836447,2015-07-30,NCI PDMR Tumor Characterization,2
5,PDMR-BL0293-F563,BL0293-F563-44,BL0293-F563-44,F,1.3.46.670589.11.17169.5.0.5244.2015071310242916371,2015-07-13,NCI PDMR Tumor Characterization,2
6,PDMR-BL0293-F563,BL0293-F563-46,BL0293-F563-46,F,1.3.46.670589.11.17169.5.0.5032.2015073010253788457,2015-07-30,NCI PDMR Tumor Characterization,2
7,PDMR-BL0293-F563,BL0293-F563-46,BL0293-F563-46,F,1.3.46.670589.11.17169.5.0.5244.2015071309510166361,2015-07-13,NCI PDMR Tumor Characterization,2
8,PDMR-BL0293-F563,BL0293-F563-48,BL0293-F563-48,F,1.3.46.670589.11.17169.5.0.5032.2015073012351494501,2015-07-30,NCI PDMR Tumor Characterization,2
9,PDMR-BL0293-F563,BL0293-F563-48,BL0293-F563-48,F,1.3.46.670589.11.17169.5.0.5244.2015071310524476381,2015-07-13,NCI PDMR Tumor Characterization,1
10,PDMR-BL0293-F563,BL0293-F563-54,BL0293-F563-54,F,1.3.46.670589.11.17169.5.0.7388.2015100811104325068,2015-10-08,NCI PDMR Tumor Characterization,2
11,PDMR-BL0293-F563,BL0293-F563-54,BL0293-F563-54,F,1.3.46.670589.11.17169.5.0.5032.2015073111211921626,2015-07-31,NCI PDMR Tumor Characterization,2
12,PDMR-BL0293-F563,BL0293-F563-54,BL0293-F563-54,F,1.3.46.670589.11.17169.5.0.5032.2015080710115814170,2015-08-07,NCI PDMR Tumor Characterization,2
13,PDMR-BL0293-F563,BL0293-F563-54,BL0293-F563-54,F,1.3.46.670589.11.17169.5.0.5244.2015071312380451411,2015-07-13,NCI PDMR Tumor Characterization,2
14,PDMR-BL0293-F563,BL0293-F563-54,BL0293-F563-54,F,1.3.46.670589.11.17169.5.0.1508.2015081411125346574,2015-08-14,NCI PDMR Tumor Characterization,2
15,PDMR-BL0293-F563,BL0293-F563-54,BL0293-F563-54,F,1.3.46.670589.11.17169.5.0.1508.2015082009173741045,2015-08-20,NCI PDMR Tumor Characterization,2
16,PDMR-BL0293-F563,BL0293-F563-54,BL0293-F563-54,F,1.3.46.670589.11.17169.5.0.6468.2015091015584243564,2015-09-10,NCI PDMR Tumor Characterization,2
17,PDMR-BL0293-F563,BL0293-F563-54,BL0293-F563-54,F,1.3.46.670589.11.17169.5.0.6548.2015082614304537650,2015-08-26,NCI PDMR Tumor Characterization,2
18,PDMR-BL0293-F563,BL0293-F563-54,BL0293-F563-54,F,1.3.46.670589.11.17169.5.0.5940.2015092309550251095,2015-09-23,NCI PDMR Tumor Characterization,2
19,PDMR-BL0293-F563,BL0293-F563-56,BL0293-F563-56,F,1.3.46.670589.11.17169.5.0.5032.2015073013053977515,2015-07-30,NCI PDMR Tumor Characterization,2
20,PDMR-BL0293-F563,BL0293-F563-56,BL0293-F563-56,F,1.3.46.670589.11.17169.5.0.5244.2015071312040803401,2015-07-13,NCI PDMR Tumor Characterization,2
21,PDMR-BL0293-F563,BL0293-F563-58,BL0293-F563-58,F,1.3.46.670589.11.17169.5.0.5032.2015073011024505467,2015-07-30,NCI PDMR Tumor Characterization,2
22,PDMR-BL0293-F563,BL0293-F563-58,BL0293-F563-58,F,1.3.46.670589.11.17169.5.0.5244.2015071313543140439,2015-07-13,NCI PDMR Tumor Characterization,2
23,PDMR-BL0293-F563,BL0293-F563-60,BL0293-F563-60,F,1.3.46.670589.11.17169.5.0.7388.2015100813104823086,2015-10-08,NCI PDMR Tumor Characterization,2
24,PDMR-BL0293-F563,BL0293-F563-60,BL0293-F563-60,F,1.3.46.670589.11.17169.5.0.5032.2015073112343324648,2015-07-31,NCI PDMR Tumor Characterization,2
25,PDMR-BL0293-F563,BL0293-F563-60,BL0293-F563-60,F,1.3.46.670589.11.17169.5.0.5032.2015080711114253180,2015-08-07,NCI PDMR Tumor Characterization,2
26,PDMR-BL0293-F563,BL0293-F563-60,BL0293-F563-60,F,1.3.46.670589.11.17169.5.0.5244.2015071315033376459,2015-07-13,NCI PDMR Tumor Characterization,2
27,PDMR-BL0293-F563,BL0293-F563-60,BL0293-F563-60,F,1.3.46.670589.11.17169.5.0.1508.2015081411365837580,2015-08-14,NCI PDMR Tumor Characterization,2
28,PDMR-BL0293-F563,BL0293-F563-60,BL0293-F563-60,F,1.3.46.670589.11.17169.5.0.1508.2015082010051366055,2015-08-20,NCI PDMR Tumor Characterization,2
29,PDMR-BL0293-F563,BL0293-F563-60,BL0293-F563-60,F,1.3.46.670589.11.17169.5.0.6468.2015090815535080246,2015-09-08,NCI PDMR Tumor Characterization,2
30,PDMR-BL0293-F563,BL0293-F563-60,BL0293-F563-60,F,1.3.46.670589.11.17169.5.0.6548.2015082614584015664,2015-08-26,NCI PDMR Tumor Characterization,2
31,PDMR-BL0293-F563,BL0293-F563-60,BL0293-F563-60,F,1.3.46.670589.11.17169.5.0.5940.2015092310233765105,2015-09-23,NCI PDMR Tumor Characterization,2
32,PDMR-BL0293-F563,BL0293-F563-62,BL0293-F563-62,F,1.3.46.670589.11.17169.5.0.5032.2015073014552082529,2015-07-30,NCI PDMR Tumor Characterization,2
33,PDMR-BL0293-F563,BL0293-F563-62,BL0293-F563-62,F,1.3.46.670589.11.17169.5.0.5244.2015071316141447483,2015-07-13,NCI PDMR Tumor Characterization,2
34,PDMR-BL0293-F563,BL0293-F563-64,BL0293-F563-64,F,1.3.46.670589.11.17169.5.0.5032.2015073015441244572,2015-07-30,NCI PDMR Tumor Characterization,2
35,PDMR-BL0293-F563,BL0293-F563-64,BL0293-F563-64,F,1.3.46.670589.11.17169.5.0.5244.2015071315421061473,2015-07-13,NCI PDMR Tumor Characterization,2
36,PDMR-BL0293-F563,BL0293-F563-66,BL0293-F563-66,F,1.3.46.670589.11.17169.5.0.5032.2015073011282518481,2015-07-30,NCI PDMR Tumor Characterization,2
37,PDMR-BL0293-F563,BL0293-F563-66,BL0293-F563-66,F,1.3.46.670589.11.17169.5.0.5244.2015071316492158493,2015-07-13,NCI PDMR Tumor Characterization,2
38,PDMR-BL0293-F563,BL0293-F563-68,BL0293-F563-68,F,1.3.46.670589.11.17169.5.0.5032.2015073008545125431,2015-07-30,NCI PDMR Tumor Characterization,2
39,PDMR-BL0293-F563,BL0293-F563-68,BL0293-F563-68,F,1.3.46.670589.11.17169.5.0.5244.2015071314273122449,2015-07-13,NCI PDMR Tumor Characterization,2
40,PDMR-BL0293-F563,BL0293-F563-72,BL0293-F563-72,F,1.3.46.670589.11.17169.5.0.7388.2015100812193653076,2015-10-08,NCI PDMR Tumor Characterization,2
41,PDMR-BL0293-F563,BL0293-F563-72,BL0293-F563-72,F,1.3.46.670589.11.17169.5.0.5032.2015073113123899658,2015-07-31,NCI PDMR Tumor Characterization,2
42,PDMR-BL0293-F563,BL0293-F563-72,BL0293-F563-72,F,1.3.46.670589.11.17169.5.0.5032.2015080711523673190,2015-08-07,NCI PDMR Tumor Characterization,2
43,PDMR-BL0293-F563,BL0293-F563-72,BL0293-F563-72,F,1.3.46.670589.11.17169.5.0.5244.2015071410480601553,2015-07-14,NCI PDMR Tumor Characterization,2
44,PDMR-BL0293-F563,BL0293-F563-72,BL0293-F563-72,F,1.3.46.670589.11.17169.5.0.1508.2015081412024188594,2015-08-14,NCI PDMR Tumor Characterization,2
45,PDMR-BL0293-F563,BL0293-F563-72,BL0293-F563-72,F,1.3.46.670589.11.17169.5.0.1508.2015082010142246061,2015-08-20,NCI PDMR Tumor Characterization,2
46,PDMR-BL0293-F563,BL0293-F563-72,BL0293-F563-72,F,1.3.46.670589.11.17169.5.0.6468.2015090815171341232,2015-09-08,NCI PDMR Tumor Characterization,2
47,PDMR-BL0293-F563,BL0293-F563-72,BL0293-F563-72,F,1.3.46.670589.11.17169.5.0.6548.2015082615463767682,2015-08-26,NCI PDMR Tumor Characterization,2
48,PDMR-BL0293-F563,BL0293-F563-72,BL0293-F563-72,F,1.3.46.670589.11.17169.5.0.5940.2015092311103702119,2015-09-23,NCI PDMR Tumor Characterization,2
49,PDMR-BL0293-F563,BL0293-F563-74,BL0293-F563-74,F,1.3.46.670589.11.17169.5.0.5032.2015073009213047437,2015-07-30,NCI PDMR Tumor Characterization,2
50,PDMR-BL0293-F563,BL0293-F563-74,BL0293-F563-74,F,1.3.46.670589.11.17169.5.0.5244.2015071408233279505,2015-07-14,NCI PDMR Tumor Characterization,2
51,PDMR-BL0293-F563,BL0293-F563-78,BL0293-F563-78,F,1.3.46.670589.11.17169.5.0.7388.2015100809365939054,2015-10-08,NCI PDMR Tumor Characterization,2
52,PDMR-BL0293-F563,BL0293-F563-78,BL0293-F563-78,F,1.3.46.670589.11.17169.5.0.5032.2015073110510538612,2015-07-31,NCI PDMR Tumor Characterization,2
53,PDMR-BL0293-F563,BL0293-F563-78,BL0293-F563-78,F,1.3.46.670589.11.17169.5.0.5032.2015080615315941102,2015-08-06,NCI PDMR Tumor Characterization,2
54,PDMR-BL0293-F563,BL0293-F563-78,BL0293-F563-78,F,1.3.46.670589.11.17169.5.0.5244.2015071409412186533,2015-07-14,NCI PDMR Tumor Characterization,2
55,PDMR-BL0293-F563,BL0293-F563-78,BL0293-F563-78,F,1.3.46.670589.11.17169.5.0.1508.2015081411023424568,2015-08-14,NCI PDMR Tumor Characterization,2
56,PDMR-BL0293-F563,BL0293-F563-78,BL0293-F563-78,F,1.3.46.670589.11.17169.5.0.1508.2015082009100460039,2015-08-20,NCI PDMR Tumor Characterization,2
57,PDMR-BL0293-F563,BL0293-F563-78,BL0293-F563-78,F,1.3.46.670589.11.17169.5.0.12048.2015091016112459008,2015-09-10,NCI PDMR Tumor Characterization,2
58,PDMR-BL0293-F563,BL0293-F563-78,BL0293-F563-78,F,1.3.46.670589.11.17169.5.0.6548.2015082612263340640,2015-08-26,NCI PDMR Tumor Characterization,2
59,PDMR-BL0293-F563,BL0293-F563-78,BL0293-F563-78,F,1.3.46.670589.11.17169.5.0.5940.2015092309150302089,2015-09-23,NCI PDMR Tumor Characterization,2
60,PDMR-BL0293-F563,BL0293-F563-80,BL0293-F563-80,F,1.3.46.670589.11.17169.5.0.5032.2015073016111674582,2015-07-30,NCI PDMR Tumor Characterization,2
61,PDMR-BL0293-F563,BL0293-F563-80,BL0293-F563-80,F,1.3.46.670589.11.17169.5.0.5244.2015071412434101573,2015-07-14,NCI PDMR Tumor Characterization,2
62,PDMR-BL0293-F563,BL0293-F563-82,BL0293-F563-82,F,1.3.46.670589.11.17169.5.0.5032.2015072911263926305,2015-07-29,NCI PDMR Tumor Characterization,2
63,PDMR-BL0293-F563,BL0293-F563-82,BL0293-F563-82,F,1.3.46.670589.11.17169.5.0.5244.2015071413542622593,2015-07-14,NCI PDMR Tumor Characterization,2
64,PDMR-BL0293-F563,BL0293-F563-88,BL0293-F563-88,F,1.3.46.670589.11.17169.5.0.5032.2015073110003241596,2015-07-31,NCI PDMR Tumor Characterization,2
65,PDMR-BL0293-F563,BL0293-F563-88,BL0293-F563-88,F,1.3.46.670589.11.17169.5.0.5244.2015071413201613583,2015-07-14,NCI PDMR Tumor Characterization,2
